{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T05:55:33Z","timestamp":1769925333993,"version":"3.49.0"},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,10,1]]},"DOI":"10.2169\/internalmedicine.7066-21","type":"journal-article","created":{"date-parts":[[2021,4,4]],"date-time":"2021-04-04T22:07:23Z","timestamp":1617574043000},"page":"3149-3153","source":"Crossref","is-referenced-by-count":4,"title":["<i>BCR\/ABL1<\/i>-positive B-lymphoblastic Lymphoma Successfully Treated with Dasatinib-combined Chemotherapy"],"prefix":"10.2169","volume":"60","author":[{"given":"Chika","family":"Yamada","sequence":"first","affiliation":[{"name":"Department of Hematology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimitsu","family":"Shimomura","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimimori","family":"Kamijyo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madoka","family":"Kanda-Kato","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yoshioka","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Cortelazzo S, Ponzoni M, Ferreri AJM, Hoelzer D. Lymphoblastic lymphoma. Crit Rev Oncol Hematol 79: 330-343, 2011.","DOI":"10.1016\/j.critrevonc.2010.12.003"},{"key":"2","unstructured":"2. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues [Internet]. 2017 [cited 2020 Aug 1]. Available from: https:\/\/publications.iarc.fr\/Book-And-Report-Series\/Who-Classification-Of-Tumours\/WHO-Classification-Of-Tumours-Of-Haematopoietic-And-Lymphoid-Tissues-2017"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Borowitz MJ, Croker BP, Metzgar RS. Lymphoblastic lymphoma with the phenotype of common acute lymphoblastic leukemia. Am J Clin Pathol 79: 387-391, 1983.","DOI":"10.1093\/ajcp\/79.3.387"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Burkhardt B, Hermiston ML. Lymphoblastic lymphoma in children and adolescents: review of current challenges and future opportunities. Br J Haematol 185: 1158-1170, 2019.","DOI":"10.1111\/bjh.15793"},{"key":"5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1182\/blood.V59.3.549.549","volume":"59","author":"A Bernard","year":"1982","unstructured":"5. Bernard A, Murphy SB, Melvin S, et al. Non-T, non-B lymphomas are rare in childhood and associated with cutaneous tumor. Blood 59: 549-554, 1982.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Lin P, Jones D, Dorfman DM, Medeiros LJ. Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement. Am J Surg Pathol 24: 1480-1490, 2000.","DOI":"10.1097\/00000478-200011000-00003"},{"key":"7","unstructured":"7. Alshomar A, El Fakih R. Philadelphia chromosome-positive lymphoblastic lymphoma - Is it rare or underdiagnosed? Hematol Oncol Stem Cell Ther 2018."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Iwamuro M, Kawai Y, Yamawaki Y, Takata K, Yamamoto K. Precursor B Lymphoblastic lymphoma Involving the Stomach. Case Rep Gastrointest Med 2013: e930918, 2013.","DOI":"10.1155\/2013\/930918"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Jabbour E, Kantarjian H. Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring. Am J Hematol 95: 691-709, 2020.","DOI":"10.1002\/ajh.25792"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Zhu J, Zhang S, Zhu L, et al. Primary testicular Ph-positive B lymphoblastic lymphoma: an unusual presentation and review. Cancer Biol Ther 16: 1122-1127, 2015.","DOI":"10.1080\/15384047.2015.1056412"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Boddu P, Yin CC, Kanagal-Shamanna R, et al. An unsuspected finding of t (9; 22): a rare case of Philadelphia chromosome-positive B-lymphoblastic lymphoma. Case Rep Hematol 2017: 2413587, 2017.","DOI":"10.1155\/2017\/2413587"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Dragani M, Andreani G, Fava C, et al. Philadelphia-positive lymphoblastic lymphoma: a case report and review of the literature. Stem Cell Investig 6: 17, 2019.","DOI":"10.21037\/sci.2019.06.06"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Sadrzadeh H, Huck AE, Chen Y-B, Hasserjian RP, Fathi AT. Philadelphia chromosome positive B-cell lymphoblastic lymphoma isolated to bone. Leuk Lymphoma 54: 2052-2054, 2013.","DOI":"10.3109\/10428194.2012.760735"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Takahashi T, Ichikawa S, Ichinohasama R, Harigae H. BCR-ABL1 positive lymphoblastic lymphoma - Should it be treated like a B-lymphoblastic leukemia with t (9; 22); BCR-ABL1? Leuk Lymphoma 61: 1265-1267, 2020.","DOI":"10.1080\/10428194.2019.1706736"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Iacobucci I, Mullighan CG. Genetic basis of acute lymphoblastic leukemia. J Clin Oncol 35: 975-983, 2017.","DOI":"10.1200\/JCO.2016.70.7836"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Laport GG, Alvarnas JC, Palmer JM, et al. Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen. Blood 112: 903-909, 2018.","DOI":"10.1182\/blood-2008-03-143115"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Fo\u00e0 R, Vitale A, Vignetti M, et al. Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 118: 6521-6528, 2011.","DOI":"10.1182\/blood-2011-05-351403"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ravandi F. Current management of Philadelphia chromosome positive ALL and the role of stem cell transplantation. Hematology 2017: 22-27, 2017.","DOI":"10.1182\/asheducation-2017.1.22"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Shen S, Chen X, Cai J, et al. Effect of dasatinib vs imatinib in the treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: A randomized clinical trial. JAMA Oncol 6: 358, 2020.","DOI":"10.1001\/jamaoncol.2019.5868"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Porkka K, Koskenvesa P, Lund\u00e1n T, et al. Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia. Blood 112: 1005-1012, 2008.","DOI":"10.1182\/blood-2008-02-140665"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/19\/60_7066-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T05:05:15Z","timestamp":1633151115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/19\/60_7066-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":20,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7066-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,1]]},"article-number":"7066-21"}}